Vigil Neuro Announces It Is Launching ALSP Programs
Vigil is conducting an observational natural history study with ALSP patients to better understand the disease and help us inform the clinical development of VGL101. Vigil engages and collaborates with patient communities, caregivers, and advocacy groups to understand their needs.
Vigil strives to alleviate the burden and to improve the lives of those struggling with devastating neurodegenerative diseases.